Ryan J. Watts - Net Worth and Insider Trading

Ryan J. Watts Net Worth

The estimated net worth of Ryan J. Watts is at least $66 Million dollars as of 2024-11-05. Ryan J. Watts is the President and CEO of Denali Therapeutics Inc and owns about 2,438,411 shares of Denali Therapeutics Inc (DNLI) stock worth over $66 Million. Details can be seen in Ryan J. Watts's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ryan J. Watts has not made any transactions after 2024-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ryan J. Watts

To

Ryan J. Watts Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ryan J. Watts owns 1 companies in total, including Denali Therapeutics Inc (DNLI) .

Click here to see the complete history of Ryan J. Watts’s form 4 insider trades.

Insider Ownership Summary of Ryan J. Watts

Ticker Comapny Transaction Date Type of Owner
DNLI Denali Therapeutics Inc 2024-10-18 director & President and CEO

Ryan J. Watts Latest Holdings Summary

Ryan J. Watts currently owns a total of 1 stock. Ryan J. Watts owns 2,438,411 shares of Denali Therapeutics Inc (DNLI) as of October 18, 2024, with a value of $66 Million.

Latest Holdings of Ryan J. Watts

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DNLI Denali Therapeutics Inc 2024-10-18 2,438,411 27.21 66,349,163

Holding Weightings of Ryan J. Watts


Ryan J. Watts Form 4 Trading Tracker

According to the SEC Form 4 filings, Ryan J. Watts has made a total of 31 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 31 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 40,000 shares on October 18, 2024, which brought Ryan J. Watts around $1 Million.

Insider Trading History of Ryan J. Watts

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ryan J. Watts Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ryan J. Watts Ownership Network

Ownership Network List of Ryan J. Watts

No Data

Ownership Network Relation of Ryan J. Watts

Insider Network Chart

Ryan J. Watts Owned Company Details

What does Denali Therapeutics Inc do?

Who are the key executives at Denali Therapeutics Inc?

Ryan J. Watts is the director & President and CEO of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include CFO and Treasurer Steve E. Krognes , COO and Secretary Alexander O. Schuth , and Chief Medical Officer Carole Ho .

Denali Therapeutics Inc (DNLI) Insider Trades Summary

Over the past 18 months, Ryan J. Watts made 8 insider transaction in Denali Therapeutics Inc (DNLI) with a net sale of 131,985. Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 25,506 shares made by Vicki L Sato , a net sale of 83,768 shares made by Alexander O. Schuth , and a net sale of 54,249 shares made by Carole Ho .

In summary, during the past 3 months, insiders sold 113,507 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 113,507 shares. During the past 18 months, 459,258 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 459,258 shares.

Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Denali Therapeutics Inc Insider Transactions

No Available Data

Ryan J. Watts Mailing Address

Above is the net worth, insider trading, and ownership report for Ryan J. Watts. You might contact Ryan J. Watts via mailing address: C/o Denali Therapeutics Inc., 151 Oyster Point Blvd., 2nd Floor, South San Francisco Ca 94080.